GGrantIndex
← Leaderboards

Ryan Ashok Shenvi

Harvard University

$11,457,647
Attributed
$13,955,018
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY200825
$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,955,018 · 7

By mechanism

R01$7,038,892 · 4
R35$6,362,107 · 1
R56$470,533 · 1
F32$83,486 · 1

Top collaborators

Others in their field

Top investigators on “Chemistry

Research focus

ChemistryReactionAreaBiologicalChemical SynthesisComplexPharmaceutical PreparationsFamilyNatural ProductsDesignNovel TherapeuticsMolecularPharmacophoreCouplingRoutePhenotypeAlkaloidsScaffoldInvestigationCombinatorialBindingFoundationsLigandsPathway Interactions

Grant awards (29)

Mapping brain-wide opioid actions by profiling neuronal activities and in vivo cellular target engagement$830,063
R01 · FY2025 · DA
Unusual Pharmacophores and New Tools for Cross-Coupling$704,352
R35 · FY2025 · GM · contact PI
Deconvolution of Galbulimima bark pharmacology through chemical synthesis and target assignment$663,419
R01 · FY2025 · AT · contact PI
Mapping brain-wide opioid actions by profiling neuronal activities and in vivo cellular target engagement$830,063
R01 · FY2024 · DA
Deconvolution of Galbulimima bark pharmacology through chemical synthesis and target assignment$721,096
R01 · FY2024 · AT · contact PI
Unusual Pharmacophores and New Tools for Cross-Coupling$692,868
R35 · FY2024 · GM · contact PI
Unusual Pharmacophores and New Tools for Cross-Coupling$249,850
R35 · FY2024 · GM · contact PI
Mapping brain-wide opioid actions by profiling neuronal activities and in vivo cellular target engagement$839,850
R01 · FY2023 · DA
Unusual Pharmacophores and New Tools for Cross-Coupling$692,868
R35 · FY2023 · GM · contact PI
Deconvolution of Galbulimima bark pharmacology through chemical synthesis and target assignment$276,925
R01 · FY2023 · AT · contact PI
Unusual Pharmacophores and New Tools for Cross-Coupling$71,258
R35 · FY2023 · GM · contact PI
Unusual Pharmacophores and New Tools for Cross-Coupling$679,470
R35 · FY2022 · GM · contact PI
Deconvolution of Galbulimima bark pharmacology through chemical synthesis and target assignment$470,533
R56 · FY2022 · AT · contact PI
Unusual Pharmacophores and New Tools for Cross-Coupling$643,518
R35 · FY2021 · GM · contact PI
Unusual Pharmacophores and New Tools for Cross-Coupling$642,405
R35 · FY2020 · GM · contact PI
Unusual Pharmacophores and New Tools for Cross-Coupling$70,912
R35 · FY2020 · GM · contact PI
Unusual Pharmacophores and New Tools for Cross-Coupling$641,371
R35 · FY2019 · GM · contact PI
Unusual Pharmacophores and New Tools for Cross-Coupling$640,375
R35 · FY2018 · GM · contact PI
Unusual Pharmacophores and New Tools for Cross-Coupling$632,860
R35 · FY2017 · GM · contact PI
New Methods and Strategies for the Synthesis of Anticancer Alkaloids$365,750
R01 · FY2016 · GM · contact PI
Synthesis of Antimalarial ICTs Using Biosynthetic Logic$355,560
R01 · FY2016 · GM · contact PI
New Methods and Strategies for the Synthesis of Anticancer Alkaloids$360,050
R01 · FY2015 · GM · contact PI
Synthesis of Antimalarial ICTs Using Biosynthetic Logic$350,948
R01 · FY2015 · GM · contact PI
New Methods and Strategies for the Synthesis of Anticancer Alkaloids$360,050
R01 · FY2014 · GM · contact PI
Synthesis of Antimalarial ICTs Using Biosynthetic Logic$351,186
R01 · FY2014 · GM · contact PI
Synthesis of Antimalarial ICTs Using Biosynthetic Logic$373,882
R01 · FY2013 · GM · contact PI
New Methods and Strategies for the Synthesis of Anticancer Alkaloids$360,050
R01 · FY2013 · GM · contact PI
Synthesis of nuphar thiophane dimers: developing pertinent chemical methods$38,640
F32 · FY2009 · GM · contact PI
Synthesis of nuphar thiophane dimers: developing pertinent chemical methods$44,846
F32 · FY2008 · GM · contact PI